Results
|
1.
|
|
|
2.
|
|
|
3.
|
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia. [electronic resource] by
- Latuske, Emily-Marie
- Stamm, Hauke
- Klokow, Marianne
- Vohwinkel, Gabi
- Muschhammer, Jana
- Bokemeyer, Carsten
- Jücker, Manfred
- Kebenko, Maxim
- Fiedler, Walter
- Wellbrock, Jasmin
Producer: 20180424
In:
Oncotarget vol. 8
Availability: No items available.
|
|
4.
|
ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts. [electronic resource] by
- Kebenko, Maxim
- Drenckhan, Astrid
- Gros, Stephanie J
- Jücker, Manfred
- Grabinski, Nicole
- Ewald, Florian
- Grottke, Astrid
- Schultze, Alexander
- Izbicki, Jakob R
- Bokemeyer, Carsten
- Wellbrock, Jasmin
- Fiedler, Walter
Producer: 20150825
In:
Cellular signalling vol. 27
Availability: No items available.
|
|
5.
|
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. [electronic resource] by
- Fiedler, Walter
- Kayser, Sabine
- Kebenko, Maxim
- Janning, Melanie
- Krauter, Jürgen
- Schittenhelm, Marcus
- Götze, Katharina
- Weber, Daniela
- Göhring, Gudrun
- Teleanu, Veronica
- Thol, Felicitas
- Heuser, Michael
- Döhner, Konstanze
- Ganser, Arnold
- Döhner, Hartmut
- Schlenk, Richard F
Producer: 20150805
In:
British journal of haematology vol. 169
Availability: No items available.
|
|
6.
|
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors. [electronic resource] by
- Kebenko, Maxim
- Goebeler, Marie-Elisabeth
- Wolf, Martin
- Hasenburg, Annette
- Seggewiss-Bernhardt, Ruth
- Ritter, Barbara
- Rautenberg, Beate
- Atanackovic, Djordje
- Kratzer, Andrea
- Rottman, James B
- Friedrich, Matthias
- Vieser, Eva
- Elm, Stefanie
- Patzak, Ingrid
- Wessiepe, Dorothea
- Stienen, Sabine
- Fiedler, Walter
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 7
Availability: No items available.
|
|
7.
|
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia. [electronic resource] by
- Vey, Norbert
- Delaunay, Jacques
- Martinelli, Giovanni
- Fiedler, Walter
- Raffoux, Emmanuel
- Prebet, Thomas
- Gomez-Roca, Carlos
- Papayannidis, Cristina
- Kebenko, Maxim
- Paschka, Peter
- Christen, Randolph
- Guarin, Ernesto
- Bröske, Ann-Marie
- Baehner, Monika
- Brewster, Michael
- Walz, Antje-Christine
- Michielin, Francesca
- Runza, Valeria
- Meresse, Valerie
- Recher, Christian
Producer: 20180125
In:
Oncotarget vol. 7
Availability: No items available.
|
|
8.
|
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial). [electronic resource] by
- Krauter, Jürgen
- Fiedler, Walter
- Schlenk, Richard F
- Paschka, Peter
- Thol, Felicitas
- Lübbert, Michael
- Wattad, Mohammed
- Verbeek, Mareike
- Könecke, Christian
- Neuhaus, Barbara
- Papkalla, Armin
- Kebenko, Maxim
- Janning, Melanie
- Döhner, Konstanze
- Gaidzik, Verena I
- Becker, Heiko
- Greil, Christine
- Reimer, Peter
- Götze, Katharina S
- Döhner, Hartmut
- Ganser, Arnold
- Heuser, Michael
Producer: 20190708
In:
British journal of haematology vol. 183
Availability: No items available.
|